Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Condition(s):Prostatic NeoplasmsLast Updated:January 13, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Prostatic NeoplasmsLast Updated:January 13, 2020Completed
Condition(s):Castration-Resistant Prostate Carcinoma; Double-Negative Prostate Carcinoma; Metastatic Prostate Carcinoma; Prostate Adenocarcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:September 28, 2023Terminated
Condition(s):Prostate NeoplasmsLast Updated:April 12, 2013Completed
Condition(s):Neoadjuvant TherapyLast Updated:January 5, 2023Recruiting
Condition(s):Renal InsufficiencyLast Updated:November 19, 2012Completed
Condition(s):Prostate CancerLast Updated:March 18, 2020Completed
Condition(s):Castration-resistant Prostate Cancer; Stage IV Prostate CancerLast Updated:July 5, 2019Completed
Condition(s):Castration-Resistant Prostate Carcinoma; Prostate Adenocarcinoma Without Neuroendocrine Differentiation; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:March 4, 2024Active, not recruiting
Condition(s):Prostatic Neoplasms; Prostate CancerLast Updated:July 2, 2013Completed
Condition(s):Metastatic Castration-resistant Prostate Cancer (mCRPC)Last Updated:March 4, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.